London startup to trial drug aimed at preventing cancer therapy side effects
A London-based startup is set to begin trials for a new drug aimed at preventing these dangerous side effects. The trial is scheduled to commence in early 2024 and will involve a diverse group of cancer patients undergoing various treatment regimens. The initiative has garnered attention from both the medical community and investors, highlighting the … Read more